Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haoyue Shan
Observed name:
Shan, Haoyue
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
Observed institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
ORCID:
0009-0001-6998-6643
Observed ORCID:
0009-0001-6998-6643
OpenAlex ID:
A5023978128
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
2024
·
Ibrahim Aldoss
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
·
22
Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
2025
·
Badri Modi
, Dat Ngo
, et al.
·
Bone Marrow Transplantation
·
14
PDF
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation
2026
·
Jorge M. Ramos Perez
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
·
3
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ ALL With High Disease Burden
2025
·
Jose Tinajero
, Kim Nguyen
, et al.
·
American Journal of Hematology
·
3
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
2023
·
Ibrahim Aldoss
, Haoyue Shan
, et al.
·
Blood
·
2
PDF
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients
2023
·
Jeannine S McCune
, Saro H Armenian
, et al.
·
Journal of Oncology Pharmacy Practice
·
2
PDF
AML-491 Real World Practice of FLAG-Idarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience
2022
·
Brian Lee
, Amanda Blackmon
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission
2026
·
Ibrahim Aldoss
, Lior Goldberg
, et al.
·
Blood Advances
·
1
CAR T‑Cell Therapy as a Bridging Strategy to Second Transplant in Relapsed B‑Cell ALL
2026
·
Vaibhav Agrawal
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant in Older (≥60 Years) Adults
2026
·
Rusha Bhandari
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
Post-transplant cyclophosphamide-based graft-verses-host disease (GVHD) prophylaxis is associated with a low incidence of fibrotic chronic GVHD after allogeneic hematopoietic cell transplantation across diverse donor types
2025
·
Klara Kim
, Dat Ngo
, et al.
·
Blood
PDF
The addition of venetoclax to FLAG IDA or FCE in relapsed or refractory (R/R) acute myeloid leukemia (AML)
2025
·
Jose Tinajero
, Dat Ngo
, et al.
·
Blood
PDF
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Transplant in Older (≥60 Years) Adults
2025
·
Rusha Bhandari
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
Correlation of Serum Ferritin with Liver Iron Concentration Measured By Magnetic Resonance Imaging in Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplant
2025
·
Adam P Braun
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
Real World Outcomes of Belumosudil for Treatment of Chronic Graft-Versus-Host Disease: A Single Center Experience
2025
·
Badri Modi
, Dat Ngo
, et al.
·
Transplantation and Cellular Therapy
Use of half red blood cell units in oncology patients during severe shortages to extend hospital supply
2024
·
Lefan Zhuang
, Haoyue Shan
, et al.
·
Transfusion
Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients 75 Years and Older: Another Age Barrier Crossed?
2023
·
Paul Koller
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
Long Term Outcomes of Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in the Era of Oral Tyrosine Kinase Inhibitors
2023
·
Paul Koller
, Haoyue Shan
, et al.
·
Transplantation and Cellular Therapy
Long Term Outcomes of Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in the Era of Oral Tyrosine Kinase Inhibitors
2022
·
Paul B. Koller
, Haoyue Shan
, et al.
·
Blood
Frequent Early Geriatric Complications after Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Adults Impairs Disability-Free Survival (DiFS)
2022
·
Jorge M. Ramos Perez
, Haoyue Shan
, et al.
·
Blood
Poster: AML-491 Real World Practice of FLAG-Idarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience
2022
·
Brian Lee
, Amanda Blackmon
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
23
Citation count:
49
H-index:
3
I10-index:
2
Year
Topic
Type